Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Labcorp Holdings Inc. (LH) shares fell 1.34% to $271.99 on Wednesday, underperforming the broader market as the S&P 500 and Dow Jones rose. This marks the stock's eighth consecutive day of losses, with LH trading 7.40% below its 52-week high. Trading volume exceeded the 50-day average. Compared to competitors, Labcorp's performance was mixed against IQVIA, Centene, and Teladoc Health.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Labcorp Holdings Inc. (LH) slipped 1.34% to $271.99 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.38% to 7,572.40 and the Dow Jones Industrial Average rising 0.29% to 52,658.64.
This was the stock's eighth consecutive day of losses.
Labcorp Holdings Inc. closed 7.40% below its 52-week high of $293.72, which the company achieved on October 21st.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as IQVIA Holdings Inc. (IQV) fell 0.49% to $206.81, Centene Corp. (CNC) fell 3.07% to $66.61, and Teladoc Health Inc. (TDOC) rose 4.85% to $9.72.
Trading volume (809,488) eclipsed its 50-day average volume of 631,418.
Data source: Dow Jones Market Data, FactSet. Data compiled July 15, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-15-26 1703ET
